Aspen Neuroscience Begins Third Cohort in Parkinson’s Disease Stem Cell Therapy Trial with Commercial Formulation

Aspen’s trial advances with a commercial-ready, patient-derived cell therapy aiming to improve Parkinson’s outcomes and streamline clinical delivery.

BlueRock Therapeutics Begins Phase III Trial of Stem Cell Therapy for Parkinson’s Disease

The exPDite-2 trial will evaluate the safety and effectiveness of donor-derived stem cell therapy in Parkinson’s disease patients.

RBI Launching Phase 2 Brain Stem Cell Injection Trial for Alzheimer’s

The trial will inject autologous stem cells directly into the brain to bypass the blood-brain-barrier.

DoD-Funded Stem Cell Trial Expands to Phase II for Traumatic Brain Injury

A new clinical trial in Texas will evaluate stem cell therapy’s potential to improve outcomes for adults with chronic TBI.

New Trial: Umbilical Cord Stem Cell-Derived Exosome Nasal Drops for Neurodegenerative Diseases

Researchers will test whether nasal drops containing stem cell-derived vesicles can safely benefit people with a range of neurodegenerative diseases.

New Trial: Mesenchymal Stem Cell Exosomes for Preventing and Treating Organ Failure After Aortic Dissection Surgery

Researchers in China are testing whether exosomes can help prevent or treat organ failure after aortic dissection surgery.

Hope Biosciences Launches Phase Ib/IIa Stem Cell Trial for Early Alzheimer’s Disease

Hope Biosciences will study whether stem cell therapy can reduce inflammation or slow Alzheimer’s progression in a new clinical trial.

Stem Cell Trial: iPSCs for Repairing Airway Damage in COPD

The study will test whether induced pluripotent stem cells can help repair airway damage in people with COPD.

Stem Cell Trial: BlueRock Launches Study of iPSC-Derived Photoreceptor Cell Therapy for Inherited Retinal Diseases

The trial will test whether lab-grown photoreceptor cells can be safely transplanted to help people with inherited vision loss.

Stem Cell and Spinal Stimulation Trial for Chronic Spinal Cord Injury

The study will test whether combining umbilical cord stem cells and spinal cord stimulation can safely help people with chronic spinal cord injury.

Stem Cell Trial: Umbilical Cord MSCs to Prevent Lung Disease in Preterm Infants

Researchers will test if umbilical cord stem cell infusions can safely reduce lung disease in extremely premature infants.

New Trial: iPSC-Derived Exosome Therapy for Moyamoya Disease

Researchers are testing whether exosomes from stem cells can enhance blood vessel repair for Moyamoya patients after surgery.

New Trial: Umbilical Cord Mesenchymal Stem Cells for Lupus

The trial will investigate whether umbilical cord stem cell therapy can calm the autoimmune condition.

BlueRock Therapeutics Begins Phase 1/2a Trial of Stem Cell Therapy OpCT-001 for Retinal Diseases

The Bayer owned company just starting dosing patients with OpCT-001, an iPSC-derived cell therapy aiming to restore vision in inherited retinal diseases.

Longeveron Gains FDA Approval to Begin Phase 2 Stem Cell Trial for Children with Heart Disease

Longeveron will evaluate if it's stem cell candidate, laromestrocel, could target pediatric dilated cardiomyopathy

NextCell Pharma Completes Patient Dosing in Pediatric Diabetes Stem Cell Study

The company has concluded dosing in its largest pediatric diabetes trial, evaluating ProTrans therapy's safety and insulin-preserving potential

Vertex Reports Promising Results from Stem Cell Trial for Type 1 Diabetes

Vertex recently presented encouraging Phase 1/2 results for zimislecel, a stem cell-derived therapy showing sustained insulin production in type 1 diabetes patients.

NurExone reports enhanced scalability and clinical readiness for upcoming exosome-based clinical trials for neurological conditions

The Israeli regenerative medicine company is moving one step closer to clinical trials for serious neurological indications such as TBI, spinal cord injury, etc.
x
Subscribe
Subscribe

Stay updated on Regenerative Medicine

Subscribe